| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $316.4M | +46.4% |
| R&D Expense | $22.3M | +96.3% |
| SG&A Expense | $124.0M | +47.2% |
| Operating Income | -$35.3M | +11.3% |
| Interest Expense | $28.4M | +137.9% |
| Pre-tax Income | -$62.7M | -11.8% |
| Income Tax | -$14.8M | -9.8% |
| Net Income | -$47.9M | -12.4% |
| EPS (Basic) | -$3.05 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $48.2M | -51.9% |
| Accounts Receivable | $165.4M | +28.7% |
| Inventory | $105.4M | +29.0% |
| Current Assets | $344.3M | +7.0% |
| Total Assets | $760.1M | -1.5% |
| Current Liabilities | $99.4M | +13.6% |
| Long-term Debt | $285.7M | -0.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$31.2M | -1039.3% |
| Capital Expenditures | $8.9M | +247.1% |
| Investing Cash Flow | -$15.7M | +85.1% |
| Financing Cash Flow | -$5.1M | -102.6% |
| Free Cash Flow | -$40.1M | -5339.1% |
| +10.3% |
| EPS (Diluted) | -$3.05 | +10.3% |
| Total Liabilities |
| $421.5M |
| +2.1% |
| Stockholders' Equity | $313.7M | -6.0% |